Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy

Cancer Immunology, Immunotherapy

Volumn 59, Issue 9, 2010, Pages 1313-1323

  Nguyen, Minh C ^a   Tu, Guang Huan ^a   Koprivnikar, Kathryn E ^a   Gonzalez Edick, Melissa ^a   Jooss, Karin U ^a   Harding, Thomas C ^a,b  

^a CELL GENESYS INC   (United States)

^b FIVE PRIME THERAPEUTICS INC   (United States)

Author keywords

Autoantibody; Biomarker; Immunotherapy; Prostate cancer; Protein microarray; Tumor antigen

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; DOCETAXEL; GALECTIN 8; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; PROSTATE SPECIFIC ANTIGEN; T CELL ALTERNATIVE READING FRAME PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; PROTEIN MICROARRAY; SURVIVAL TIME; TREATMENT RESPONSE; UPREGULATION;

ANTIBODIES; BIOMARKERS, PHARMACOLOGICAL; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; GALECTINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIGH-THROUGHPUT SCREENING ASSAYS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROGNOSIS; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77955516209     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-010-0858-5     Document Type: Article

References (32)

1. ME Kaighn KS Narayan Y Ohnuki JF Lechner LW Jones 1979 Establishment and characterization of a human prostatic carcinoma cell line (PC-3) Invest Urol 17 16 23 1:STN:280:DyaE1M7ptlKlsg%3D%3D 447482
2. JS Horoszewicz, et al. 1980 The LNCaP cell line-a new model for studies on human prostatic carcinoma Prog Clin Biol Res 37 115 132 1:STN:280: DyaL3c3ht1alsg%3D%3D 7384082
3. DZ Chang, et al. 2004 Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines Hematology 9 207 215 10.1080/ 10245330410001701549 1:CAS:528:DC%2BD2cXkvVWktrw%3D 15204102
4. AJ Fleetwood AD Cook JA Hamilton 2005 Functions of granulocyte-macrophage colony-stimulating factor Crit Rev Immunol 25 405 428 10.1615/CritRevImmunol. v25.i5.50 1:CAS:528:DC%2BD2MXhtFyiu7bM 16167889 (Pubitemid 43068934)
5. WJ Urba, et al. 2008 Treatment of biochemical recurrence of prostate cancer with granulocyte-macrophage colony-stimulating factor secreting, allogeneic Cellular Immunotherapy J Urol 180 2011 2017 1:CAS:528: DC%2BD1cXhtlWqs73P
6. EJ Small, et al. 2007 Granulocyte macrophage colony-stimulating factor-secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer Clin Cancer Res 13 3883 3891 10.1158/1078-0432.CCR-06-2937 1:CAS:528:DC%2BD2sXntFymtrg%3D 17606721 (Pubitemid 47037595)
7. CS Higano, et al. 2008 Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer Cancer 113 975 984 10.1002/cncr.23669 1:CAS:528:DC%2BD1cXhtFSlur3F 18646045
8. Higano C et al (2009) A phase III trial of GVAX immunotherapy for prostate cancer versus docetaxel plus prednisone in asymptomatic, castration-resistant prostate cancer (CRPC). American Society of Clinical Oncology's Genitourinary Cancer Symposium, Orlando, Florida LBA150
9. S Halabi, et al. 2003 Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer J Clin Oncol 21 1232 1237 10.1200/JCO.2003.06.100 12663709 (Pubitemid 46606398)
10. ZZ Su, et al. 1996 Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family Proc Natl Acad Sci USA 93 7252 7257 10.1073/pnas.93.14.7252 1:CAS:528:DyaK28Xkt1Wgsb4%3D 8692978 (Pubitemid 26243535)
11. N Bidon-Wagner JP Le Pennec 2004 Human galectin-8 isoforms and cancer Glycoconj J 19 557 563 10.1023/B:GLYC.0000014086.38343.98 14758080
12. M Essand, et al. 1999 High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate Proc Natl Acad Sci USA 96 9287 9292 10.1073/pnas.96.16.9287 1:CAS:528:DyaK1MXltVequ7k%3D 10430935 (Pubitemid 29374747)
13. CD Wolfgang M Essand JJ Vincent B Lee I Pastan 2000 TARP: a nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus Proc Natl Acad Sci USA 197 9437 9442 10.1073/pnas.160270597
14. CD Wolfgang M Essand B Lee I Pastan 2001 T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin Cancer Res 61 8122 8126 1:CAS:528:DC%2BD3MXovVShs70%3D 11719440
15. I Leav, et al. 2010 Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer Am J Pathol 176 393 401 10.2353/ajpath.2010.090521 1:CAS:528:DC%2BC3cXhs12rtLY%3D 19948822
16. H Maeda, et al. 2004 The T cell receptor gamma chain alternate reading frame protein (TARP), a prostate-specific protein localized in mitochondria J Biol Chem 279 24561 24568 10.1074/jbc.M402492200 1:CAS:528:DC%2BD2cXksV2itbw%3D 15150260 (Pubitemid 38725322)
17. Y Imai, et al. 2002 Cloning and characterization of the highly expressed ETEA gene from blood cells of atopic dermatitis patients Biochem Biophys Res Commun 297 1282 1290 10.1016/S0006-291X(02)02380-X 1:CAS:528: DC%2BD38XnsFSntr4%3D 12372427 (Pubitemid 35216386)
18. A Domagala M Kurpisz 2001 CD52 antigen-a review Med Sci Monit 7 325 331 1:CAS:528:DC%2BD3MXivVajsr0%3D 11257744
19. Y Gao, et al. 2006 Activation of the selenoprotein SEPS1 gene expression by pro-inflammatory cytokines in HepG2 cells Cytokine 33 246 251 10.1016/j.cyto.2006.02.005 1:CAS:528:DC%2BD28Xjs1Gqu78%3D 16574427
20. Y Mamane, et al. 1999 Interferon regulatory factors: the next generation Gene 237 1 14 10.1016/S0378-1119(99)00262-0 1:CAS:528:DyaK1MXmtlOmu7c%3D 10524230 (Pubitemid 29406192)
21. E Hartmann, et al. 1993 A tetrameric complex of membrane proteins in the endoplasmic reticulum Eur J Biochem 214 375 381 10.1111/j.1432-1033.1993. tb17933.x 1:CAS:528:DyaK3sXltFWmur0%3D 7916687
22. HY Song JD Dunbar YX Zhang D Guo DB Donner 1995 Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor J Biol Chem 270 3574 3581 10.1074/jbc.270.8.3574 1:CAS:528: DyaK2MXjvVyrsro%3D 7876093
23. Y Oda, et al. 2006 Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation J Cell Biol 172 383 393 10.1083/jcb.200507057 1:CAS:528:DC%2BD28XhtFGntr4%3D 16449189 (Pubitemid 43187935)
24. L Hjelmqvist, et al. 2002 ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins Genome Biol 3 1 16 10.1186/gb-2002-3-6- research0027
25. SJ Felts, et al. 2000 The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties J Biol Chem 275 3305 3312 10.1074/jbc.275.5.3305 1:CAS:528:DC%2BD3cXhtVygsLY%3D 10652318 (Pubitemid 30083032)
26. RH Houtkooper FM Vaz 2008 Cardiolipin, the heart of mitochondrial metabolism Cell Mol Life Sci 65 2493 2506 10.1007/s00018-008-8030-5 1:CAS:528:DC%2BD1cXhtVansrzE 18425414
27. Y Ye Y Shibata C Yun D Ron TA Rapoport 2004 A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol Nature 429 841 847 10.1038/nature02656 1:CAS:528:DC%2BD2cXltVKltLs%3D 15215856 (Pubitemid 38843292)
28. WS Cheng V Giandomenico I Pastan M Essand 2003 Characterization of the androgen-regulated prostate-specific T cell receptor gamma-chain alternate reading frame protein (TARP) promoter Endocrinology 144 3433 3440 10.1210/en.2003-0121 1:CAS:528:DC%2BD3sXlslGjsbY%3D 12865322 (Pubitemid 36904419)
29. T Schlomm, et al. 2005 Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis Int J Oncol 27 713 720 1:CAS:528:DC%2BD2MXpvVWmtbk%3D 16077921
30. B Carlsson TH Tötterman M Essand 2004 Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARP Prostate 61 161 170 10.1002/pros.20091 1:CAS:528:DC%2BD2cXosVKlsr4%3D 15305339 (Pubitemid 39244703)
31. S Oh, et al. 2004 Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells Cancer Res 64 2610 2618 10.1158/0008-5472.CAN-03-2183 1:CAS:528:DC%2BD2cXis1yju7w%3D 15059918 (Pubitemid 38523919)
32. H Kobayashi, et al. 2005 Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARP Clin Cancer Res 11 3869 3878 10.1158/1078-0432.CCR-04-2238 1:CAS:528:DC%2BD2MXktFyqsrs%3D 15897588 (Pubitemid 40685608)